Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates
- PMID: 26241423
- DOI: 10.1097/AOG.0000000000000975
Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates
Abstract
Objective: To evaluate how implementation of a best-practice alert, a reminder of clinical guidelines within the electronic medical record, in combination with the recommended change in immunization timing from postpartum to antepartum, affected tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) rates, and to examine the association of vaccination with local pertussis attack rates.
Methods: A Tdap best-practice alert was introduced into the electronic prenatal charting system in June 2013. The best-practice alert was designed to appear starting at 32 weeks of gestation and to reappear at every subsequent encounter until vaccine acceptance was recorded or delivery occurred. The overall acceptance rate was then compared with postpartum vaccination rates at our institution from the previous year. Records of pertussis cases in children younger than 2 years of age diagnosed since 2012 in Dallas County were also reviewed to correlate local trends with vaccination efforts.
Results: Of the 10,201 women offered Tdap during prenatal care, 9,879 (96.8%) ultimately accepted. This is compared with a 48% (5,064 of 10,600) Tdap postpartum immunization rate in the year prior, before introduction of the best-practice alert. The incidence of pertussis among neonates born to mothers who received prenatal care at Parkland Hospital showed a nonsignificant decline from 13 cases per 10,000 deliveries (19 of 14,834, 95% confidence interval [CI] 7-19) between January 2012 and May 2013 to seven per 10,000 deliveries during the study period (eight of 11,788, 95% CI 2-11, P=.174).
Conclusion: The use of a best-practice alert, in concert with the recommended change in timing of maternal vaccination from postpartum to antepartum, was associated with an increase in the Tdap immunization rate to 97%.
Level of evidence: II.
Similar articles
-
Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S.Am J Prev Med. 2018 Aug;55(2):159-166. doi: 10.1016/j.amepre.2018.04.013. Epub 2018 Jun 14. Am J Prev Med. 2018. PMID: 29910115 Free PMC article.
-
Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis.Clin Infect Dis. 2017 Jan 1;64(1):3-8. doi: 10.1093/cid/ciw634. Epub 2016 Sep 13. Clin Infect Dis. 2017. PMID: 27624955
-
Predictors of Low Uptake of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Immunization in Privately Insured Women in the United States.Obstet Gynecol. 2017 Apr;129(4):629-637. doi: 10.1097/AOG.0000000000001927. Obstet Gynecol. 2017. PMID: 28277354 Free PMC article.
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.Public Health. 2020 Feb;179:38-44. doi: 10.1016/j.puhe.2019.10.001. Epub 2019 Nov 11. Public Health. 2020. PMID: 31726399 Review.
Cited by
-
Vaccines in pregnancy: The dual benefit for pregnant women and infants.Hum Vaccin Immunother. 2016 Apr 2;12(4):848-56. doi: 10.1080/21645515.2015.1127485. Hum Vaccin Immunother. 2016. PMID: 26857450 Free PMC article. Review.
-
Better Together? A Mediation Analysis of French General Practitioners' Performance in Multi Professional Group Practice.Health Serv Insights. 2025 May 6;18:11786329251331128. doi: 10.1177/11786329251331128. eCollection 2025. Health Serv Insights. 2025. PMID: 40336967 Free PMC article.
-
Influenza and pertussis vaccination during pregnancy - attitudes, practices and barriers in gynaecological practices in Germany.BMC Health Serv Res. 2019 Sep 2;19(1):616. doi: 10.1186/s12913-019-4437-y. BMC Health Serv Res. 2019. PMID: 31477095 Free PMC article.
-
A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.PLoS One. 2019 Mar 28;14(3):e0214538. doi: 10.1371/journal.pone.0214538. eCollection 2019. PLoS One. 2019. PMID: 30921421 Free PMC article.
-
SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol.Cardiovasc Digit Health J. 2021 Jul 17;2(4):222-230. doi: 10.1016/j.cvdhj.2021.06.001. eCollection 2021 Aug. Cardiovasc Digit Health J. 2021. PMID: 35265912 Free PMC article.
References
-
- Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013;9:e1003418.
-
- Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1424–6.
-
- Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al.. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985–9.
-
- Wendelboe AM, Njamkep E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al.; Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26:293–9.
-
- Centers for Disease Control and Prevention (CDC). Updated recommendations for the use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131–5.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials